Europe
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
BioSpace looks at five of the top investor companies that support life sciences companies across the industry.
On Wednesday morning, the company announced that it would be undergoing a $1.36 billion takeover by global investment firm The Carlyle Group.
The company says it plans to file an IND for the candidate, dubbed CFT8919, by the middle of next year.
Companies continue to report promising data for vaccines and therapies against COVID-19. Here’s a look.
Drug development requires solid funding. Here’s who’s standing on higher ground this week with fresh investment dollars.
The purpose is to develop cell-based disease models to accelerate drug discovery and reduce development costs.
Gene therapy is still very much cutting-edge with the potential to cure incurable genetic diseases. Here’s some recent news in the space.
The UK’s Competition and Markets Authority (CMA) will determine if the deal is anti-competitive.
The Francis Crick Institute and the Latvian Institute of Organic Synthesis developed a new compound that blocks the life cycle of the mosquito-borne parasite that causes malaria.
PRESS RELEASES